Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Jazz Pharmaceuticals plc (JAZZ)

565 + Investors. Track Smart Money conviction in JAZZ. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
2Q ▲
Buyers last Q
55%

Smart Money Signals — JAZZ

Based on 569 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added JAZZ than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
569 hedge funds hold JAZZ right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +5% more funds vs a year ago

fund count last 6Q
+25 new funds entered over the past year (+5% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 55% buying

315 buying260 selling
Last quarter: 315 funds bought or added vs 260 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-42 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 59 → 57 → 134 → 92. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

61% of holders stayed for 2+ years

■ 61% conviction (2yr+) ■ 20% medium ■ 20% new
346 out of 569 hedge funds have held JAZZ for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

105 → 59 → 57 → 134 → 92 new funds/Q
New funds entering each quarter: 59 → 57 → 134 → 92. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 68% veterans vs 23% newcomers

■ 68% veterans ■ 9% 1-2yr ■ 23% new
Entry-cohort mix of 582 holders: 393 (68%) are 2+ year veterans, 55 entered 1–2 years ago, and 134 (23%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 45% AUM from top-100 funds

45% from top-100 AUM funds
57 of 565 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in JAZZ. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.7
out of 10
Low Exit Risk
Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — JAZZ

In 2026 Q1, 315 hedge funds were net buyers of JAZZ (92 opened a new position, 223 added to an existing one), while 260 reduced or exited (169 trimmed, 91 sold completely) — a 55% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 45% of total institutional value in JAZZ is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +1 funds (more new holders than closures). Total institutional holders: 569.

Hedge Fund Ownership: JAZZ

How many hedge funds hold JAZZ — quarterly history vs. share price
Quarterly hedge fund ownership of JAZZ vs. share price

Market Analysis: JAZZ

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: JAZZ

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Jazz Pharmaceuticals plc (JAZZ) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much JAZZ has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
JAZZ
+22.0%
XLV
+4.9%

JAZZ outperformed XLV by +17.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
JAZZ
+0.8%
XLV
+6.0%

Since the filing became public, JAZZ outperformed XLV by -5.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

45 top-rated funds 2 high-conviction
Consensus
7.2
/ 10
breadth
×
Elite
4.2
/ 10
conviction
Hedge Fund Positioning: JAZZ
565 + Investors

Track Smart Money conviction in JAZZ. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 565 568 -0.53%
13F Shares 64M 62M 3.56%
Total Value $11.35B $10.49B 8.21%
New Positions 91 134 -43
Increased Positions 220 174 +46
Closed Positions 94 60 +34
Reduced Positions 165 192 -27
Total Calls 8 13 -38.46%
Total Puts 9 10 -10.0%
PUT/CALL Ratio 1.12 0.77 Neutral

Statistics: JAZZ

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

565 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in JAZZ. Verified SEC 13F-HR filings.

QUARTER:
Top 25 JAZZ holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 EcoR1 Capital, LLC 13.69% 1,706,469 $322.6M
2 Polaris Capital Management, LLC 6.42% 415,366 $78.5M
3 Saturn V Capital Management LP 5.58% 162,961 $30.8M
4 Goldentree Asset Management LP 5.32% 475,550 $89.8M
5 Gmt Capital Corp 5.01% 581,000 $109.8M
6 Sofinnova Investments, Inc. 4.30% 598,327 $113.1M
7 Tri Locum Partners LP 4.21% 158,663 $30.0M
8 PFM Health Sciences, LP 3.07% 178,144 $33.7M
9 Fairbanks Capital Management, Inc. 2.72% 22,990 $4.3M
10 Graphene Investments SAS 2.20% 17,300 $3.3M
11 Rhenman & Partners Asset Management AB 1.77% 75,890 $14.3M
12 Systematic Financial Management LP 1.76% 407,114 $77.0M
13 Diadema Partners LP 1.76% 54,755 $10.4M
14 Dean Capital Management 1.66% 21,156 $4.0M
15 Harvey Capital Management Inc 1.52% 35,320 $6.7M
16 Persistent Asset Partners Ltd 1.12% 15,905 $3.0M
17 Dean Investment Associates, LLC 1.12% 41,915 $7.9M
18 Faithward Advisors, LLC 1.10% 38,339 $7.7M
19 Fuller & Thaler Asset Management, INC. 1.07% 1,676,142 $316.9M
20 Frontier Capital Management Co LLC 1.01% 517,284 $97.8M
21 Tweedy, Browne Co LLC 0.90% 60,209 $11.4M
22 Poehling Capital Management, INC. 0.90% 22,639 $4.3M
23 John G Ullman & Associates Inc 0.82% 32,833 $6.2M
24 Boston Trust Walden Corp 0.76% 488,661 $92.4M
25 AlphaCentric Advisors LLC 0.67% 3,561 $673K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Jazz Pharmaceuticals plc (JAZZ)

What does the Smart Money Trend signal show for JAZZ?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added JAZZ than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for JAZZ?

Slight buying edge — 55% buying: Last quarter: 315 funds bought or added vs 260 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for JAZZ holders?

Elite ownership — 45% AUM from top-100 funds: 57 of 565 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in JAZZ. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held JAZZ?

61% of holders stayed for 2+ years: 346 out of 569 hedge funds have held JAZZ for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Jazz Pharmaceuticals plc (JAZZ) following the 2026 Q1 hedge fund 13F filings?

As of today, JAZZ has moved +0.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -5.2%. Since the quarter end (March 31, 2026), JAZZ has gained +22.0% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →